Icl Medilab Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 31-12-2024
- Paid Up Capital ₹ 5.00 M
as on 31-12-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 140.80%
(FY 2022)
- Profit 43.19%
(FY 2022)
- Ebitda 7.41%
(FY 2022)
- Net Worth -27.58%
(FY 2022)
- Total Assets -10.49%
(FY 2022)
About Icl Medilab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kuzhuppilly Anilkumar and Umadevi Anilkumar serve as directors at the Company.
- CIN/LLPIN
U71309KL2016PTC047365
- Company No.
047365
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Icl Medilab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuzhuppilly Anilkumar  | Director | 25-Nov-2016 | Current |
| Umadevi Anilkumar | Director | 25-Nov-2016 | Current |
Financial Performance of Icl Medilab.
Icl Medilab Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 140.8% increase. The company also saw a substantial improvement in profitability, with a 43.19% increase in profit. The company's net worth observed a substantial decline by a decrease of 27.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Icl Medilab?
In 2021, Icl Medilab had a promoter holding of 92.00% and a public holding of 8.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Icl Tours & Travels Private LimitedActive 11 years 24 daysKuzhuppilly Anilkumar and Umadevi Anilkumar are mutual person
Icl Nidhi LimitedActive 9 years 2 monthsKuzhuppilly Anilkumar and Umadevi Anilkumar are mutual person
Icl Fincorp LimitedActive 33 years 1 monthKuzhuppilly Anilkumar and Umadevi Anilkumar are mutual person
Salem Erode Investments LimitedActive 93 years 8 monthsKuzhuppilly Anilkumar and Umadevi Anilkumar are mutual person
Laneseda Vanijya Pvt LtdActive 29 years 1 monthKuzhuppilly Anilkumar and Umadevi Anilkumar are mutual person
- Snow View Tex Collections Private LimitedActive 8 years 29 days
Kuzhuppilly Anilkumar and Umadevi Anilkumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Icl Medilab?
Unlock and access historical data on people associated with Icl Medilab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Icl Medilab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icl Medilab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
